Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Pharmacogenetics|May 8, 2001
Arg389Gly beta 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivoH G Xie, V Dishy, G Sofowora, et al.Pharmacogenetics|December 12, 2001
In-vivo effects of Glu298Asp endothelial nitric oxide synthase polymorphismG Sofowora, V Dishy, H G Xie, et al.Clinical Pharmacology and Therapeutics|October 1, 1995
Genetic analysis of the S-mephenytoin polymorphism in a Chinese populationS M de Morais, J A Goldstein, H G Xie, et al.Clinical Pharmacology and Therapeutics|June 29, 2000
Human beta2-adrenergic receptor polymorphisms: no association with essential hypertension in black or white AmericansH G Xie, C M Stein, R B Kim, et al.Pharmacogenetics|April 26, 2000
Frequency of functionally important beta-2 adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individualsH G Xie, C M Stein, R B Kim, et al.Pharmacogenetics|January 16, 1998
Meta-analysis of phenotype and genotype of NAT2 deficiency in Chinese populationsH G Xie, Z H Xu, D S Ou-Yang, et al.Zhonghua Nei Ke Za Zhi|February 2, 2019
[The diagnostic framework for screening Alzheimer's disease in the Chinese population]J Z Tian, H G Xie, B Qin, et al.The Journal of Pharmacology and Experimental Therapeutics|April 1, 1997
Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant alleleZ S Xiao, J A Goldstein, H G Xie, et al.Clinical Pharmacology and Therapeutics|April 24, 2003
A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockadeG G Sofowora, V Dishy, M Muszkat, et al.Clinical Pharmacology and Therapeutics|August 15, 2001
Identification of functionally variant MDR1 alleles among European Americans and African AmericansR B Kim, B F Leake, E F Choo, et al.Pageof 5